M
Marinomed Biotech AG
VSE:MARI
Marinomed Biotech AG
VSE:MARI
Price:
14
EUR
-1.75%
Market Closed
Market Cap:
€25.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
|
Acorn Energy Inc
NASDAQ:ACFN
|
US |
|
F
|
First Bank of Toyama Ltd
TSE:7184
|
JP |
|
Pritish Nandy Communications Ltd
NSE:PNC
|
IN |
Income Statement
Earnings Waterfall
Marinomed Biotech AG
Marinomed Biotech AG
Income Statement
Marinomed Biotech AG
Marinomed Biotech AG
Currency: EUR
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Revenue |
5
N/A
|
5
-1%
|
6
+29%
|
6
+4%
|
7
+6%
|
8
+17%
|
8
+3%
|
9
+15%
|
9
-3%
|
9
-3%
|
12
+32%
|
12
+2%
|
13
+13%
|
13
-2%
|
11
-13%
|
12
+8%
|
12
-5%
|
11
-2%
|
9
-19%
|
7
-28%
|
6
-3%
|
5
-26%
|
12
+151%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
(6)
|
(6)
|
(7)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(8)
|
(6)
|
(5)
|
(4)
|
(5)
|
|
| Gross Profit |
(1)
N/A
|
(1)
-44%
|
(1)
+59%
|
0
N/A
|
0
-11%
|
0
-70%
|
(1)
N/A
|
(1)
-65%
|
(2)
-55%
|
(2)
+4%
|
1
N/A
|
2
+59%
|
4
+57%
|
4
+15%
|
2
-48%
|
2
-2%
|
2
-4%
|
2
-11%
|
1
-37%
|
1
-39%
|
1
+50%
|
1
-7%
|
7
+601%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(8)
|
7
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(6)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
|
| Other Operating Expenses |
(3)
|
(2)
|
0
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
(1)
|
(1)
|
(3)
|
15
|
|
| Operating Income |
(7)
N/A
|
(7)
+1%
|
(6)
+15%
|
(5)
+20%
|
(5)
-1%
|
(5)
-3%
|
(6)
-11%
|
(6)
-6%
|
(7)
-7%
|
(7)
-2%
|
(4)
+38%
|
(4)
+12%
|
(3)
+17%
|
(3)
+8%
|
(5)
-77%
|
(5)
-3%
|
(5)
-5%
|
(5)
-3%
|
(5)
+6%
|
(6)
-9%
|
(5)
+3%
|
(7)
-28%
|
13
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
(8)
|
(7)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
(9)
|
(8)
|
(8)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
1
|
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(15)
N/A
|
(14)
+3%
|
(7)
+50%
|
(6)
+23%
|
(6)
+0%
|
(6)
-6%
|
(6)
-3%
|
(7)
-9%
|
(7)
-10%
|
(8)
-5%
|
(6)
+24%
|
(5)
+5%
|
(5)
+5%
|
(5)
0%
|
(6)
-23%
|
(7)
-3%
|
(6)
+8%
|
(6)
-2%
|
(7)
-9%
|
(7)
-1%
|
(14)
-106%
|
(16)
-10%
|
5
N/A
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Income from Continuing Operations |
(15)
|
(14)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(6)
|
(6)
|
(5)
|
(5)
|
(6)
|
(7)
|
(6)
|
(6)
|
(7)
|
(7)
|
(14)
|
(15)
|
5
|
|
| Net Income (Common) |
(15)
N/A
|
(14)
+3%
|
(7)
+50%
|
(6)
+23%
|
(6)
+0%
|
(6)
-6%
|
(6)
-3%
|
(7)
-9%
|
(7)
-10%
|
(8)
-5%
|
(6)
+22%
|
(6)
+4%
|
(5)
+5%
|
(5)
0%
|
(6)
-19%
|
(7)
-3%
|
(6)
+8%
|
(6)
-2%
|
(7)
-9%
|
(7)
-1%
|
(14)
-106%
|
(15)
-9%
|
5
N/A
|
|
| EPS (Diluted) |
-10.94
N/A
|
-10.56
+3%
|
-5.09
+52%
|
-3.77
+26%
|
-3.79
-1%
|
-3.97
-5%
|
-4.09
-3%
|
-4.44
-9%
|
-4.95
-11%
|
-5.09
-3%
|
-3.99
+22%
|
-3.77
+6%
|
-3.66
+3%
|
-3.57
+2%
|
-4.27
-20%
|
-4.24
+1%
|
-3.81
+10%
|
-4.08
-7%
|
-4.48
-10%
|
-4.46
+0%
|
-9.25
-107%
|
-8.67
+6%
|
2.98
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
